U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07394725) titled 'Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management' on Nov. 14, 2025.
Brief Summary: This randomized controlled trial at Sahiwal Teaching Hospital (April 2024-March 2025) compared azithromycin and erythromycin for managing preterm premature rupture of membranes (PPROM) in 250 women (28-33+6 weeks gestation). Participants received either azithromycin 500 mg once daily or erythromycin 250 mg every six hours for seven days.
Study Start Date: April 01, 2024
Study Type: INTERVENTIONAL
Condition:
Pre-term Premature Rupture of Membranes
Intervention:
DRUG: Erythromycin
Erythromy...